Ozempic and Sleep: Insomnia, Sleep Quality & Sleep Apnea (2026)

The honest answer is that Ozempic's relationship with sleep runs in two directions. On one hand, insomnia is not a prominently labeled common side effect of semaglutide, and when people do report disturbed sleep it is usually indirect — nighttime nausea or reflux, needing the bathroom, low blood sugar at night (especially when Ozempic is combined with insulin or a sulfonylurea), under-eating, or anxiety. On the other hand, the weight loss that GLP-1 medicines drive often improves sleep, particularly by reducing the severity of obstructive sleep apnea (OSA) and lifting overall sleep quality. The evidence here is real: the SURMOUNT-OSA trial showed major OSA improvement with the related drug tirzepatide, and in December 2024 the FDA approved Zepbound (tirzepatide) for moderate-to-severe OSA in adults with obesity — the first medication approved for that condition.^[1] Semaglutide itself is not specifically OSA-approved, but the same weight-loss pathway that helps with apnea applies. This guide covers both directions honestly, plus practical, prescriber-directed steps for protecting your sleep. Ozempic is semaglutide; see our Ozempic drug page and the broader Ozempic side effects guide for the full picture. This is general educational information, not medical advice — your prescriber manages your care.

Can Ozempic disrupt your sleep?

Sometimes — but it is worth being precise about what the evidence does and does not show. Insomnia is not a prominently labeled common side effect of semaglutide. It does not appear as a headline adverse reaction in the way that nausea, diarrhea, vomiting, and constipation do, and the consumer summaries do not flag sleeplessness as a typical effect.^[4] So when someone sleeps poorly after starting Ozempic, the disturbance is usually indirect — a downstream consequence of the drug's other effects rather than a direct action on the brain's sleep machinery. The reports that do exist are largely anecdotal or secondary, which is an important distinction: it means the problem is often addressable by fixing the underlying driver.

The most common indirect routes to disrupted sleep on Ozempic are nighttime gastrointestinal symptoms (nausea, reflux, or needing the bathroom from diarrhea), low blood sugar overnight — which can cause night sweats and waking, and which is far more likely when semaglutide is combined with insulin or a sulfonylurea — under-eating during the day so that hunger or a metabolic dip interferes with rest, and anxiety around starting a new medicine.^[4] None of these is the drug "causing insomnia" in a direct pharmacologic sense; each is a knock-on effect you and your prescriber can usually manage.

Can Ozempic improve your sleep?

Yes — and this is the better-evidenced direction. The weight loss that GLP-1 medicines produce often improves sleep, and the clearest example is obstructive sleep apnea (OSA), in which the upper airway repeatedly narrows or collapses during sleep, fragmenting rest and dropping oxygen levels. OSA is strongly linked to excess weight, so losing weight tends to reduce its severity — fewer breathing interruptions per hour, better oxygenation, and often better-quality, less-fragmented sleep. Beyond apnea, many people simply find that as their weight comes down their overall sleep quality improves.

The trial evidence is concrete. SURMOUNT-OSA, published in the New England Journal of Medicine in 2024, tested the related GLP-1/GIP medicine tirzepatide in adults with obesity and moderate-to-severe OSA and found a large reduction in the apnea-hypopnea index (the standard measure of breathing interruptions per hour) compared with placebo.^[1] On the strength of that trial, the FDA in December 2024 approved Zepbound (tirzepatide) for moderate-to-severe OSA in adults with obesity — the first drug ever approved to treat the condition.^[1] The principle was already visible with an earlier GLP-1 medicine: the SCALE Sleep Apnea trial showed that weight loss on liraglutide 3.0 mg reduced OSA severity versus placebo.^[2] A peer-reviewed review of GLP-1 receptor agonists in obesity-related OSA reaches the same broad conclusion — the airway benefit travels with the weight loss.^[3]

Weight loss, sleep apnea, and not stopping CPAP on your own

If you are losing weight on Ozempic and you have OSA, your apnea may genuinely improve — but improvement is not the same as cure, and the decision to change OSA treatment belongs with your clinician, guided by objective testing. The standard of care is to confirm a change in apnea severity with a sleep study before stepping down therapy, not to assume the problem has resolved because you feel better or have lost weight.

• Do not stop CPAP (or another OSA treatment) on your own. Even with meaningful weight loss, OSA can persist; stopping abruptly without medical advice can bring back the breathing interruptions, daytime sleepiness, and cardiovascular strain that the therapy was protecting against.^[1]
• Let a sleep study guide any change. If you think your apnea has improved, your prescriber can arrange repeat testing to measure it objectively before adjusting CPAP pressure or considering whether therapy can be reduced.^[3]
• Treat the GLP-1 medicine as a complement, not a swap. In the SURMOUNT-OSA program, tirzepatide was studied both with and without CPAP — the medicine and existing therapy were not framed as mutually exclusive, and the weight loss works alongside, not instead of, proper OSA care.^[1]
• Report worsening daytime symptoms. Loud snoring, witnessed pauses in breathing, morning headaches, and excessive daytime sleepiness are reasons to be evaluated for sleep apnea or to revisit existing treatment — these warrant a clinical conversation regardless of weight changes.^[3]

Practical, prescriber-directed ways to protect your sleep

Because most Ozempic-related sleep disruption is indirect — traced to nighttime GI symptoms, overnight low blood sugar, under-eating, or anxiety — the fixes target those drivers. The following are general, commonly-discussed strategies, and all of them are prescriber-directed. Do not change your Ozempic dose, start supplements, or adjust other medications without talking to your clinician.

• Keep a consistent sleep schedule and basic sleep hygiene. Regular bed and wake times, a cool dark room, and winding down without screens give your body the best chance to adapt while it adjusts to the medication.
• Time your meals to reduce nighttime GI symptoms. Lighter, earlier evening meals — and avoiding large, fatty, or spicy meals close to bedtime — can cut the nausea and reflux that interrupt sleep, since semaglutide slows stomach emptying.^[4]
• Manage overnight low-blood-sugar risk with your prescriber. If you also take insulin or a sulfonylurea, ask your clinician whether the dose or timing should change to reduce night-time lows that cause sweating and waking; do not self-adjust those medications.^[4]
• Eat enough during the day. A strong appetite suppressant makes it easy to under-fuel; regular, protein-forward, balanced meals even when you are not hungry help prevent the hunger and metabolic dips that disturb rest.^[4]
• Mind your dose-escalation weeks. GI side effects, and any sleep disruption travelling with them, tend to be heaviest just after each dose increase; your prescriber can hold you at the current dose longer if a step is rough.^[4]
• Seek help for persistent insomnia or signs of sleep apnea. Sleep trouble that does not settle, or symptoms like loud snoring, witnessed breathing pauses, gasping, or heavy daytime sleepiness, deserve a clinical evaluation rather than being chalked up to the medication.^[3]

For the full list of what's common versus serious on this medicine, see Ozempic side effects, and for the basics of how the drug works and who prescribes it, see the Ozempic drug page.

The bottom line

Ozempic and sleep is a two-way story. Insomnia is not a prominently labeled side effect, and the sleep disruption people do report is usually indirect — nighttime GI symptoms, overnight low blood sugar (mostly with insulin or a sulfonylurea), under-eating, or anxiety — and therefore usually fixable with your prescriber's help.^[4] At the same time, the weight loss GLP-1 medicines drive often improves sleep, especially by reducing obstructive sleep apnea severity; that benefit is well enough established that the related drug tirzepatide (Zepbound) is now FDA-approved for moderate-to-severe OSA in adults with obesity.^[1] Semaglutide is not specifically OSA-approved, but the same weight-loss pathway helps.^[2][3] The practical playbook is steady sleep habits, meal timing that limits nighttime GI symptoms, careful management of low-blood-sugar risk, eating enough during the day, and — crucially — never stopping CPAP or other OSA therapy without medical advice.